• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤科光动力治疗期间获得的原卟啉IX测量值的回归分析

Regression Analysis of Protoporphyrin IX Measurements Obtained During Dermatological Photodynamic Therapy.

作者信息

Tyrrell Jessica, Paterson Cheryl, Curnow Alison

机构信息

European Centre for Environment and Human Health, University of Exeter Medical School, University of Exeter, Knowledge Spa, Royal Cornwall Hospital, Truro, Cornwall TR1 3HD, UK.

出版信息

Cancers (Basel). 2019 Jan 10;11(1):72. doi: 10.3390/cancers11010072.

DOI:10.3390/cancers11010072
PMID:30634715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6356372/
Abstract

Photodynamic therapy (PDT) is a light activated drug therapy that can be used to treat a number of dermatological cancers and precancers. Improvement of efficacy is required to widen its application. Clinical protoporphyrin IX (PpIX) fluorescence data were obtained using a pre-validated, non-invasive imaging system during routine methyl aminolevulinate (MAL)-PDT treatment of 172 patients with licensed dermatological indications (37.2% actinic keratosis, 27.3% superficial basal cell carcinoma and 35.5% Bowen's disease). Linear and logistic regressions were employed to model any relationships between variables that may have affected PpIX accumulation and/or PpIX photobleaching during irradiation and thus clinical outcome at three months. Patient age was found to be associated with lower PpIX accumulation/photobleaching, however only a reduction in PpIX photobleaching appeared to consistently adversely affect treatment efficacy. Clinical clearance was reduced in lesions located on the limbs, hands and feet with lower PpIX accumulation and subsequent photobleaching adversely affecting the outcome achieved. If air cooling pain relief was employed during light irradiation, PpIX photobleaching was lower and this resulted in an approximate three-fold reduction in the likelihood of achieving clinical clearance. PpIX photobleaching during the first treatment was concluded to be an excellent predictor of clinical outcome across all lesion types.

摘要

光动力疗法(PDT)是一种光激活药物疗法,可用于治疗多种皮肤癌和癌前病变。需要提高其疗效以扩大其应用范围。在对172例有许可皮肤适应症的患者(37.2%为光化性角化病,27.3%为浅表基底细胞癌,35.5%为鲍恩病)进行常规甲基氨基酮戊酸(MAL)-PDT治疗期间,使用经过预先验证的非侵入性成像系统获取临床原卟啉IX(PpIX)荧光数据。采用线性回归和逻辑回归对可能影响照射期间PpIX积累和/或PpIX光漂白从而影响三个月临床结果的变量之间的任何关系进行建模。发现患者年龄与较低的PpIX积累/光漂白有关,然而,似乎只有PpIX光漂白的降低会持续对治疗效果产生不利影响。四肢、手和脚上的病变临床清除率降低,较低的PpIX积累和随后的光漂白对所取得的结果产生不利影响。如果在光照射期间采用空气冷却止痛,PpIX光漂白较低,这导致实现临床清除的可能性降低约三倍。得出结论,首次治疗期间的PpIX光漂白是所有病变类型临床结果的良好预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/0c3662da698c/cancers-11-00072-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/13221e0b5b5b/cancers-11-00072-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/74c3137ef715/cancers-11-00072-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/7f22a54b7358/cancers-11-00072-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/e353421366d5/cancers-11-00072-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/0c3662da698c/cancers-11-00072-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/13221e0b5b5b/cancers-11-00072-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/74c3137ef715/cancers-11-00072-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/7f22a54b7358/cancers-11-00072-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/e353421366d5/cancers-11-00072-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee3/6356372/0c3662da698c/cancers-11-00072-g005.jpg

相似文献

1
Regression Analysis of Protoporphyrin IX Measurements Obtained During Dermatological Photodynamic Therapy.皮肤科光动力治疗期间获得的原卟啉IX测量值的回归分析
Cancers (Basel). 2019 Jan 10;11(1):72. doi: 10.3390/cancers11010072.
2
The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.实时皮肤氨基酮戊酸光动力疗法(MAL-PDT)期间原卟啉IX光漂白与后续临床结果之间的关系。
Lasers Surg Med. 2010 Sep;42(7):613-9. doi: 10.1002/lsm.20943.
3
The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy.空气冷却止痛对原卟啉 IX 光漂白和皮肤病光动力治疗临床疗效的影响。
J Photochem Photobiol B. 2011 Apr 4;103(1):1-7. doi: 10.1016/j.jphotobiol.2010.12.011. Epub 2010 Dec 28.
4
Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.利用无创荧光成像和定量技术监测标准皮肤科氨甲酰基乙酸甲酯光动力疗法中光敏剂原卟啉 IX 的积累和消散。
Photodiagnosis Photodyn Ther. 2011 Mar;8(1):30-8. doi: 10.1016/j.pdpdt.2010.11.001. Epub 2010 Dec 17.
5
Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.开发一种手持式荧光成像设备,以研究健康和患病皮肤中原卟啉IX荧光的特性。
Photodiagnosis Photodyn Ther. 2015 Dec;12(4):630-9. doi: 10.1016/j.pdpdt.2015.10.002. Epub 2015 Oct 20.
6
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.比较肢端和非肢端部位皮肤肿瘤在甲氨基酮戊酸光动力疗法中卟啉IX 的积累和破坏。
Br J Dermatol. 2011 Jun;164(6):1362-8. doi: 10.1111/j.1365-2133.2011.10265.x. Epub 2011 May 13.
7
An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.一种新型铁螯合原卟啉IX前药用于增强光动力疗法的实验研究。
Lasers Surg Med. 2018 Jul;50(5):552-565. doi: 10.1002/lsm.22809. Epub 2018 Mar 31.
8
Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy.在标准皮肤科氨甲酰基-L- 丙氨酸光动力疗法的光照阶段中,原卟啉 IX 光漂白。
Photodiagnosis Photodyn Ther. 2010 Dec;7(4):232-8. doi: 10.1016/j.pdpdt.2010.09.005. Epub 2010 Nov 5.
9
The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.原卟啉 IX 诱导的光动力疗法联合与不联合铁螯合作用对常氧、低氧和高氧条件下培养的人鳞状癌细胞的影响。
Photodiagnosis Photodyn Ther. 2013 Dec;10(4):575-82. doi: 10.1016/j.pdpdt.2013.06.006. Epub 2013 Aug 8.
10
A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy.5-氨基酮戊酸和甲氨基酮戊酸诱导的光动力疗法中的荧光、光漂白和疼痛的定量比较。
Photochem Photobiol. 2011 Jan-Feb;87(1):242-9. doi: 10.1111/j.1751-1097.2010.00829.x. Epub 2010 Nov 15.

引用本文的文献

1
Daylight Photodynamic Therapy for Actinic Keratosis and Field Cancerization: A Narrative Review.日光光动力疗法治疗光化性角化病和场癌化:一项叙述性综述
Cancers (Basel). 2025 Mar 20;17(6):1050. doi: 10.3390/cancers17061050.
2
The use of photodynamic therapy in medical practice.光动力疗法在医学实践中的应用。
Front Oncol. 2024 May 8;14:1373263. doi: 10.3389/fonc.2024.1373263. eCollection 2024.
3
Novel Iron-Chelating Prodrug Significantly Enhanced Fluorescence-Mediated Detection of Glioma Cells Experimentally In Vitro.新型铁螯合前药显著增强了体外实验中荧光介导的胶质瘤细胞检测。

本文引用的文献

1
Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.原卟啉 IX 蓄积增加不能提高光动力疗法治疗光化性角化病的疗效:一项随机对照试验。
Br J Dermatol. 2017 May;176(5):1241-1246. doi: 10.1111/bjd.15098. Epub 2017 Mar 8.
2
Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.开发一种手持式荧光成像设备,以研究健康和患病皮肤中原卟啉IX荧光的特性。
Photodiagnosis Photodyn Ther. 2015 Dec;12(4):630-9. doi: 10.1016/j.pdpdt.2015.10.002. Epub 2015 Oct 20.
3
Pharmaceutics. 2023 Nov 24;15(12):2668. doi: 10.3390/pharmaceutics15122668.
4
Clinical assessment of a low-cost, hand-held, smartphone-attached intraoral imaging probe for 5-aminolevulinic acid photodynamic therapy monitoring and guidance.一种低成本、手持式、与智能手机相连的口腔内成像探头用于 5-氨基酮戊酸光动力治疗监测和引导的临床评估。
J Biomed Opt. 2023 Aug;28(8):082809. doi: 10.1117/1.JBO.28.8.082809. Epub 2023 Jul 21.
5
Global Trends and Research Progress of Photodynamic Therapy in Skin Cancer: A Bibliometric Analysis and Literature Review.皮肤癌光动力治疗的全球趋势与研究进展:文献计量分析与文献综述
Clin Cosmet Investig Dermatol. 2023 Feb 21;16:479-498. doi: 10.2147/CCID.S401206. eCollection 2023.
6
Fluorescence-guided surgery for non-melanoma and melanoma skin cancer: Case series and a brief review of the literature.非黑色素瘤和黑色素瘤皮肤癌的荧光引导手术:病例系列及文献简要综述
Photodermatol Photoimmunol Photomed. 2021 Nov;37(6):541-544. doi: 10.1111/phpp.12687. Epub 2021 May 7.
7
Artificial Intelligence in Dermatology: A Practical Introduction to a Paradigm Shift.皮肤病学中的人工智能:范式转变的实用入门
Indian Dermatol Online J. 2020 Nov 8;11(6):881-889. doi: 10.4103/idoj.IDOJ_388_20. eCollection 2020 Nov-Dec.
8
Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.光动力疗法治疗基底细胞癌:未来研究重点的临床背景。
Molecules. 2020 Nov 18;25(22):5398. doi: 10.3390/molecules25225398.
9
Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.智能手机荧光成像仪定量测定皮肤中基于原卟啉 IX 的光动力疗法。
J Biomed Opt. 2019 Dec;25(6):1-13. doi: 10.1117/1.JBO.25.6.063802.
10
A Retrospective Study of the Diagnostic Accuracy of In Vivo Reflectance Confocal Microscopy for Basal Cell Carcinoma Diagnosis and Subtyping.一项关于活体反射共聚焦显微镜对基底细胞癌诊断及亚型诊断准确性的回顾性研究。
J Clin Med. 2019 Apr 3;8(4):449. doi: 10.3390/jcm8040449.
Correction for tissue optical properties enables quantitative skin fluorescence measurements using multi-diameter single fiber reflectance spectroscopy.
对组织光学特性进行校正,可使用多直径单光纤反射光谱法进行定量皮肤荧光测量。
J Dermatol Sci. 2015 Jul;79(1):64-73. doi: 10.1016/j.jdermsci.2015.03.017. Epub 2015 Apr 7.
4
Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy.与光动力疗法相关的皮肤癌中原卟啉IX荧光检测技术。
Photonics Lasers Med. 2013 Nov 1;2(4):287-303. doi: 10.1515/plm-2013-0030.
5
Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosis.采用宽带反射光谱校正的双通道红/蓝荧光剂量测定法可测量光化性角化病光动力治疗过程中原卟啉IX的生成量。
J Biomed Opt. 2014;19(7):75002. doi: 10.1117/1.JBO.19.7.075002.
6
Fluorescence Photodiagnostics and Photobleaching Studies of Cancerous Lesions using Ratio Imaging and Spectroscopic Techniques.荧光光诊断和光漂白研究使用比率成像和光谱技术的癌性病变。
Lasers Med Sci. 2000 Jan;15(1):63-72. doi: 10.1007/s101030050049.
7
Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging.使用空间频域成像技术对基底细胞癌和鳞状细胞癌模型中卟吩姆钠(PpIX)浓度进行定量分析。
Biomed Opt Express. 2013 Apr 1;4(4):531-7. doi: 10.1364/BOE.4.000531. Epub 2013 Mar 6.
8
European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.欧洲光动力疗法指南第 1 部分:治疗输送和当前适应证——光化性角化病、鲍文病、基底细胞癌。
J Eur Acad Dermatol Venereol. 2013 May;27(5):536-44. doi: 10.1111/jdv.12031. Epub 2012 Nov 26.
9
How mainstream medicine sees photodynamic therapy in the United Kingdom.主流医学在英国如何看待光动力疗法。
J Natl Compr Canc Netw. 2012 Oct 1;10 Suppl 2:S69-74. doi: 10.6004/jnccn.2012.0180.
10
Oxygen saturation and perfusion changes during dermatological methylaminolaevulinate photodynamic therapy.氧饱和度和灌注变化在皮肤科氨甲酰基-L- 苏氨酸光动力治疗期间。
Br J Dermatol. 2011 Dec;165(6):1323-31. doi: 10.1111/j.1365-2133.2011.10554.x. Epub 2011 Nov 17.